Virtu Financial LLC Neurocrine Biosciences Inc Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

A detailed history of Virtu Financial LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Virtu Financial LLC holds 17,230 shares of NBIX stock, worth $2.12 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

17,230

Holding current value

$2.12 Million

% of portfolio

0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	BUY	$114.58 - $153.15 $1.97 Million - $2.64 Million	17,230 New	17,230 $1.99 Million
Q1 2024 May 20, 2024	BUY	$130.4 - $143.74 $549,244 - $605,432	4,212 New	4,212 $581,000
Q2 2023 Jul 27, 2023	BUY	$89.53 - $104.87 $479,254 - $561,369	5,353 New	5,353 $505,000
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $552,413 - $634,782	-6,410 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$89.43 - $102.27 $169,469 - $193,801	1,895 Added 41.97%	6,410 $624,000
Q1 2021 May 19, 2021	SELL	$87.57 - $119.4 $133,719 - $182,323	-1,527 Reduced 25.27%	4,515 $439,000
Q4 2020 Feb 24, 2021	SELL	$86.91 - $108.33 $1.21 Million - $1.5 Million	-13,877 Reduced 69.67%	6,042 $579,000
Q3 2020 Dec 11, 2020	BUY	$96.16 - $135.15 $1.31 Million - $1.85 Million	13,655 Added 217.99%	19,919 $1.92 Million
Q2 2020 Aug 07, 2020	BUY	$85.09 - $130.36 $533,003 - $816,575	6,264 New	6,264 $764,000
Q4 2019 Feb 04, 2020	SELL	$86.8 - $118.57 $407,526 - $556,686	-4,695 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$83.82 - $101.5 $393,534 - $476,542	4,695 New	4,695 $423,000
Q2 2019 Aug 13, 2019	SELL	$72.24 - $91.27 $665,402 - $840,687	-9,211 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$69.31 - $91.53 $638,414 - $843,082	9,211 New	9,211 $812,000
Q4 2018 Jan 16, 2019	SELL	$68.32 - $124.36 $281,068 - $511,617	-4,114 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $406,792 - $517,746	4,114 New	4,114 $506,000
Q2 2018 Jul 30, 2018	SELL	$75.3 - $105.99 $549,012 - $772,773	-7,291 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$75.3 - $105.99 $636,285 - $895,615	-8,450 Reduced 53.68%	7,291 $716,000
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $1.19 Million - $1.45 Million	15,741 New	15,741 $1.31 Million

Others Institutions Holding NBIX

# of Institutions

624

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account

Virtu Financial LLC Neurocrine Biosciences Inc Transaction History